Ratings by Morgan Stanley (Matthew Harrison)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/21/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/20/2021 Atea Pharmaceuticals AVIR Maintain Equalweight
(N/A)
 
 
  Details
10/19/2021 Freeline FRLN Maintain Overweight
(N/A)
 
 
  Details
10/19/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
10/19/2021 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Vertex VRTX Maintain Underweight
(N/A)
 
 
  Details
10/12/2021 Sage Therapeutics SAGE Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Merck MRK Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Legand Biotech Corp. LEGN Maintain Overweight
(N/A)
 
 
  Details
10/12/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
10/12/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/12/2021 Amgen AMGN Maintain Equalweight
(N/A)
 
 
  Details
10/12/2021 Allovir Inc. ALVR Maintain Overweight
(N/A)
 
 
  Details
10/8/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
10/5/2021 Atea Pharmaceuticals AVIR Downgrade Equalweight
(Overweight)
42.01
(12.73)
-69.7% Details
9/14/2021 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details
9/7/2021 Cerevel Therapeutics CERE Maintain Overweight
(N/A)
 
 
  Details
9/7/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
9/7/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
9/7/2021 argenx SE ARGX Downgrade Equalweight
(Overweight)
349.07
(293.16)
-16.02% Details
9/7/2021 Vertex VRTX Downgrade Underweight
(Equalweight)
199.22
(183.52)
-7.88% Details
9/7/2021 Merck MRK Downgrade Equalweight
(Overweight)
77.12
(81.15)
5.23% Details
9/7/2021 Johnson & Johnson JNJ Downgrade Equalweight
(Overweight)
174.93
(163.72)
-6.41% Details
9/7/2021 Genmab A/S GMAB Downgrade Underweight
(Equalweight)
48.71
(46.73)
-4.06% Details
9/7/2021 Amgen AMGN Downgrade Equalweight
(Overweight)
225.96
(209.24)
-7.4% Details
8/31/2021 Adagio ADGI New Coverage Equalweight
(N/A)
30.38
(33.75)
11.09% Details
8/27/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
8/24/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
8/24/2021 Tenaya Therapeutics Inc TNYA New Coverage Overweight
(N/A)
22.67
(21.86)
-3.57% Details
8/20/2021 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Taysha Gene Therapies TSHA Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Fusion Pharmaceuticals FUSN Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Atea Pharmaceuticals AVIR Maintain Overweight
(N/A)
 
 
  Details
8/18/2021 Allovir Inc. ALVR Maintain Overweight
(N/A)
 
 
  Details
8/16/2021 Sarepta Therapeutics SRPT Maintain Equalweight
(N/A)
 
 
  Details
8/16/2021 Royalty Pharma RPRX Maintain Equalweight
(N/A)
 
 
  Details
8/16/2021 Organon & Co. OGN Maintain Equalweight
(N/A)
 
 
  Details
8/16/2021 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/16/2021 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/11/2021 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
8/11/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/11/2021 Imara Inc. IMRA Downgrade Equalweight
(Overweight)
5.90
(3.57)
-39.49% Details
8/11/2021 Fulcrum Therapeutics FULC Upgrade Overweight
(Equalweight)
8.33
(24.77)
197.36% Details
7/29/2021 Bristol-Myers Squibb Co. BMY Maintain Equalweight
(N/A)
 
 
  Details
7/29/2021 Pfizer PFE Maintain Equalweight
(N/A)
 
 
  Details
7/23/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Sigilon Therapeutics SGTX Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Seagen SGEN Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
7/16/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Alector Inc. ALEC Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 Adagene Inc ADAG Maintain Overweight
(N/A)
 
 
  Details
7/16/2021 ADC Therapeutics ADCT Maintain Overweight
(N/A)
 
 
  Details
7/12/2021 Lyell Immunopharma LYEL New Coverage Overweight
(N/A)
15.25
(13.79)
-9.57% Details
6/22/2021 Centessa Pharmaceuticals CNTA New Coverage Overweight
(N/A)
24.91
(17.00)
-31.75% Details
6/18/2021 Cerevel Therapeutics CERE New Coverage Overweight
(N/A)
13.49
(40.34)
199.04% Details
6/11/2021 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
6/10/2021 Gilead Sciences GILD Maintain Overweight
(N/A)
 
 
  Details
6/8/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
6/3/2021 BeiGene, Ltd. BGNE Maintain Overweight
(Overweight)
 
 
  Details
6/3/2021 Atea Pharmaceuticals AVIR Maintain Overweight
(Overweight)
 
 
  Details
5/25/2021 Vaccitech VACC New Coverage Overweight
(N/A)
14.58
(14.26)
-2.19% Details
5/18/2021 argenx SE ARGX Maintain Overweight
(Overweight)
 
 
  Details
5/18/2021 Fusion Pharmaceuticals FUSN Maintain Overweight
(Overweight)
 
 
  Details
5/18/2021 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(Equalweight)
 
 
  Details
5/11/2021 Galapagos NV GLPG Maintain Overweight
(Overweight)
 
 
  Details
5/10/2021 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
5/10/2021 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
5/10/2021 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
5/10/2021 Editas Medicine EDIT Maintain Underweight
(N/A)
 
 
  Details
5/10/2021 ADC Technologies ADCT Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/6/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
5/3/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(Equalweight)
 
 
  Details
4/30/2021 Vertex VRTX Maintain Equalweight
(Equalweight)
 
 
  Details
4/30/2021 Gilead Sciences GILD Maintain Overweight
(Overweight)
 
 
  Details
4/28/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
4/13/2021 Taysha Gene Therapies TSHA Maintain Overweight
(Overweight)
 
 
  Details
4/6/2021 Fusion Pharmaceuticals FUSN Maintain Overweight
(Overweight)
 
 
  Details
4/6/2021 Freeline FRLN Maintain Overweight
(Overweight)
 
 
  Details
4/6/2021 Atea Pharmaceuticals AVIR Maintain Overweight
(Overweight)
 
 
  Details
3/29/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
3/26/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
3/22/2021 Akero Therapeutics AKRO Maintain Overweight
(Overweight)
 
 
  Details
3/22/2021 ADC Technologies ADCT Maintain Overweight
(Overweight)
 
 
  Details
3/11/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
3/11/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
3/11/2021 Galapagos NV GLPG Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 argenx SE ARGX Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Taysha Gene Therapies TSHA Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Regenxbio Inc. RGNX Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Kodiak Sciences Inc. KOD Maintain Equalweight
(Equalweight)
 
 
  Details
3/8/2021 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(Equalweight)
 
 
  Details
3/8/2021 Imara Inc. IMRA Maintain Overweight
(Overweight)
 
 
  Details
3/8/2021 Fulcrum Therapeutics FULC Maintain Equalweight
(Equalweight)
 
 
  Details
3/8/2021 Adagene Inc ADAG New Coverage Overweight
(N/A)
22.99
(11.84)
-48.5% Details
3/5/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
3/2/2021 Pharvaris B.V. PHVS New Coverage Overweight
(N/A)
39.23
(15.25)
-61.13% Details
3/2/2021 Sage Therapeutics SAGE Maintain Equalweight
(Equalweight)
 
 
  Details
3/2/2021 Insmed INSM Maintain Overweight
(Overweight)
 
 
  Details
3/2/2021 Editas Medicine EDIT Maintain Underweight
(Underweight)
 
 
  Details
3/2/2021 Bolt Biotherapeutics, Inc. BOLT New Coverage Overweight
(N/A)
26.70
(12.99)
-51.35% Details
3/2/2021 bluebird bio BLUE Maintain Equalweight
(Equalweight)
 
 
  Details
2/26/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
2/25/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
2/24/2021 Huntington Bancshares HBAN Maintain Equalweight
(Equalweight)
 
 
  Details
2/18/2021 Moderna MRNA Maintain Equalweight
(Equalweight)
 
 
  Details
2/17/2021 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
2/12/2021 Seagen SGEN Maintain Equalweight
(Equalweight)
 
 
  Details
2/8/2021 Regeneron Pharma REGN Maintain Equalweight
(Equalweight)
 
 
  Details
2/5/2021 Gilead Sciences GILD Maintain Overweight
(Overweight)
 
 
  Details
2/4/2021 Biogen BIIB Maintain Overweight
(Overweight)
 
 
  Details
2/3/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
2/2/2021 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
1/26/2021 Moderna MRNA Maintain Equalweight
(N/A)
 
 
  Details
1/21/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
1/19/2021 Galapagos NV GLPG Maintain Overweight
(Equalweight)
 
 
  Details
1/19/2021 BeiGene, Ltd. BGNE Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Amgen AMGN Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Vertex VRTX Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Regenxbio Inc. RGNX Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Evelo Biosciences Inc EVLO Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Regeneron Pharma REGN Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Biogen BIIB Maintain Overweight
(Overweight)
 
 
  Details
1/19/2021 Seagen SGEN Maintain Equalweight
(Equalweight)
 
 
  Details
1/19/2021 Genmab A/S GMAB Downgrade Equalweight
(Overweight)
44.12
(46.73)
5.92% Details
1/19/2021 Gilead Sciences GILD Upgrade Overweight
(Equalweight)
62.40
(67.24)
7.76% Details
1/19/2021 Silicon Labs SLAB New Coverage Equalweight
(N/A)
135.45
(151.51)
11.86% Details
1/19/2021 Editas Medicine EDIT Downgrade Underweight
(Equalweight)
75.92
(37.82)
-50.18% Details
1/8/2021 Sarepta Therapeutics SRPT Downgrade Equalweight
(Overweight)
166.45
(80.24)
-51.79% Details
12/30/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
12/29/2020 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
12/29/2020 Sigilon Therapeutics SGTX New Coverage Equalweight
(N/A)
41.20
(5.81)
-85.9% Details
12/24/2020 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
12/16/2020 Moderna MRNA Downgrade Equalweight
(Overweight)
155.07
(326.54)
110.58% Details
12/11/2020 Gilead Sciences GILD Maintain Equalweight
(N/A)
 
 
  Details
12/4/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
12/1/2020 Sage Therapeutics SAGE Maintain Equalweight
(N/A)
 
 
  Details
11/16/2020 Sage Therapeutics SAGE Downgrade Equalweight
(Overweight)
78.00
(44.07)
-43.5% Details
11/16/2020 Kodiak Sciences Inc. KOD Downgrade Equalweight
(Overweight)
122.63
(116.00)
-5.41% Details
11/12/2020 Vertex VRTX Maintain Equalweight
(N/A)
 
 
  Details
11/11/2020 Zentalis Pharmaceuticals ZNTL Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Evelo Biosciences Inc EVLO Maintain Equalweight
(N/A)
 
 
  Details
11/11/2020 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/11/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
11/3/2020 Gilead Sciences GILD New Coverage Equalweight
(N/A)
58.15
(67.24)
15.63% Details
10/22/2020 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Zentalis Pharmaceuticals ZNTL Maintain Overweight
(N/A)
 
 
  Details
8/24/2020 Allovir Inc. ALVR New Coverage Overweight
(N/A)
30.85
(20.92)
-32.19% Details
8/21/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
8/21/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Equalweight
(N/A)
 
 
  Details
8/12/2020 Fulcrrum Therapeutics FULC Downgrade Equalweight
(Overweight)
17.12
(24.77)
44.68% Details
8/10/2020 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
8/10/2020 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
8/10/2020 Immunomedics IMMU Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/10/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/10/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
8/6/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
8/6/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
7/31/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
7/29/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/27/2020 Biogen BIIB Upgrade Overweight
(Equalweight)
278.51
(264.80)
-4.92% Details
7/15/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Kaleido Biosciences Inc. KLDO Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
7/15/2020 Cabaletta Bio Inc. CABA Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
7/15/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/15/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
7/9/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
7/8/2020 BioMarin Pharmaceutical Inc. BMRN Downgrade Equalweight
(Overweight)
127.71
(73.74)
-42.26% Details
7/8/2020 Vertex VRTX Downgrade Equalweight
(Overweight)
291.31
(183.52)
-37% Details
6/30/2020 Legand Biotech Corp. LEGN New Coverage Overweight
(N/A)
40.03
(53.08)
32.6% Details
5/28/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
5/28/2020 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
5/28/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
5/27/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
5/21/2020 Kaleido Biosciences Inc. KLDO Downgrade Equalweight
(Overweight)
6.45
(4.42)
-31.47% Details
5/21/2020 Evelo Biosciences Inc EVLO Downgrade Equalweight
(Overweight)
4.32
(7.93)
83.56% Details
5/20/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/7/2020 Immunomedics IMMU Maintain Equalweight
(N/A)
 
 
  Details
5/7/2020 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
5/7/2020 Alexion Pharmaceuticals ALXN Maintain Equalweight
(N/A)
 
 
  Details
5/6/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/4/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
5/1/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
4/28/2020 Zentalis Pharmaceuticals ZNTL New Coverage Overweight
(N/A)
30.50
(77.93)
155.51% Details
4/23/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
4/7/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
3/3/2020 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
3/3/2020 Immunomedics IMMU Maintain Equalweight
(N/A)
 
 
  Details
3/3/2020 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
3/3/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
3/3/2020 Forty Seven Inc. FTSV Downgrade Equalweight
(Overweight)
58.00
(95.51)
64.67% Details
2/26/2020 Galapagos NV GLPG Maintain Equalweight
(N/A)
 
 
  Details
2/26/2020 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
2/18/2020 Evelo Biosciences Inc EVLO Maintain Overweight
(N/A)
 
 
  Details
2/7/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
2/7/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
2/6/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
2/4/2020 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
1/31/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
1/31/2020 Alexion Pharmaceuticals ALXN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Seattle Genetics SGEN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
1/17/2020 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
1/17/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
1/17/2020 Alexion Pharmaceuticals ALXN Maintain Equalweight
(N/A)
 
 
  Details
1/17/2020 BeiGene, Ltd. BGNE New Coverage Overweight
(N/A)
167.85
(378.88)
125.73% Details
12/24/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Kodiak Sciences Inc. KOD Maintain Overweight
(N/A)
 
 
  Details
12/17/2019 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
12/17/2019 Amgen AMGN New Coverage Overweight
(N/A)
243.20
(209.24)
-13.96% Details
12/17/2019 Alexion Pharmaceuticals ALXN Downgrade Equalweight
(Overweight)
110.42
(182.01)
64.83% Details
12/10/2019 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
12/10/2019 Seattle Genetics SGEN New Coverage Equalweight
(N/A)
117.50
(171.43)
45.9% Details
12/6/2019 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
11/19/2019 Cabaletta Bio Inc. CABA New Coverage Overweight
(N/A)
14.00
(12.74)
-9% Details
11/11/2019 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
11/11/2019 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
11/6/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
11/5/2019 Kodiak Sciences Inc. KOD Maintain Overweight
(N/A)
 
 
  Details
11/1/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/1/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/1/2019 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
10/29/2019 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
10/28/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
10/28/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
10/23/2019 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
10/11/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Evelo Biosciences Inc EVLO Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
10/11/2019 Biogen BIIB Maintain Underweight
(N/A)
 
 
  Details
10/11/2019 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
10/11/2019 Alexion Pharmaceuticals ALXN Maintain Overweight
(N/A)
 
 
  Details
9/9/2019 Galapagos NV GLPG New Coverage Overweight
(N/A)
162.04
(50.93)
-68.57% Details
9/6/2019 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
9/5/2019 Incyte INCY New Coverage Equalweight
(N/A)
80.06
(65.79)
-17.82% Details
8/12/2019 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
8/9/2019 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
8/9/2019 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/6/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/6/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
8/6/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
8/6/2019 argenx SE ARGX Maintain Overweight
(N/A)
 
 
  Details
7/17/2019 BeiGene, Ltd. BGNE Maintain Overweight
(N/A)
 
 
  Details
7/15/2019 Unum Therapeutics UMRX Maintain Overweight
(N/A)
 
 
  Details
7/15/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
7/15/2019 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
7/15/2019 Biohaven Pharmaceutical Holding BHVN Maintain Equalweight
(N/A)
 
 
  Details
7/15/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/9/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
6/5/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
5/28/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
5/21/2019 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/8/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
5/1/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
4/29/2019 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
4/26/2019 Alexion Pharmaceuticals ALXn Maintain Overweight
(N/A)
 
 
  Details
4/9/2019 Biohaven Pharmaceutical Holding BHVN Downgrade Equalweight
(Overweight)
50.19
(139.90)
178.74% Details
3/4/2019 Portola Pharmaceuticals PTLA Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Biohaven Pharmaceutical Holding BHVN Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 MacroGenics MGNX Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Global Blood Therapeutics GBT Maintain Overweight
(N/A)
 
 
  Details
3/4/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
2/26/2019 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
2/25/2019 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
2/25/2019 Insmed INSM Maintain Overweight
(N/A)
 
 
  Details
2/25/2019 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
2/12/2019 Alexion Pharmaceuticals ALXN Maintain Overweight
(N/A)
 
 
  Details
2/8/2019 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
1/30/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
1/30/2019 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
1/22/2019 Immunomedics IMMU Downgrade Equalweight
(Overweight)
13.31
(87.86)
560.11% Details
1/4/2019 argenx SE ARGX New Coverage Overweight
(N/A)
98.85
(293.16)
196.57% Details
1/2/2019 Moderna MRNA New Coverage Overweight
(N/A)
15.27
(326.54)
2038.44% Details
12/20/2018 DBV Technologies S.A DBVT Maintain Equalweight
(N/A)
 
 
  Details
11/7/2018 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
11/5/2018 Galapagos NV GLPG Maintain Overweight
(N/A)
 
 
  Details
11/5/2018 bluebird bio BLUE Maintain Equalweight
(N/A)
 
 
  Details
11/5/2018 Immunomedics IMMU New Coverage Overweight
(N/A)
24.03
(13.31)
-44.61% Details
11/2/2018 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
10/31/2018 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
10/29/2018 Kodiak Sciences Inc. KOD New Coverage Overweight
(N/A)
9.56
(116.00)
1113.39% Details
10/26/2018 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
10/24/2018 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Unum Therapeutics UMRX Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Sage Therapeutics SAGE Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Regeneron Pharma REGN Maintain Equalweight
(N/A)
 
 
  Details
10/11/2018 Radius Health RDUS Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
10/11/2018 Loxo Oncology LOXO Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Global Blood Therapeutics GBT Maintain Equalweight
(N/A)
 
 
  Details
10/11/2018 Forty Seven Inc. FTSV Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Evelo Biosciences Inc EVLO Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Biohaven Pharmaceutical Holding BHVN Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
10/11/2018 Alexion Pharmaceuticals ALXN Maintain Overweight
(N/A)
 
 
  Details
9/11/2018 DBV Technologies S.A DBVT Maintain Equalweight
(N/A)
 
 
  Details
9/10/2018 Voyager Therapeutics VYGR New Coverage Equalweight
(Overweight)
19.56
(3.79)
-80.62% Details
8/13/2018 Portola Pharmaceuticals PTLA Maintain Equalweight
(N/A)
 
 
  Details
8/13/2018 Rubius RUBY New Coverage Overweight
(N/A)
21.93
(16.22)
-26.04% Details